相关实验视频

Updated: Jun 14, 2025

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

微RNA-204在调节乳腺癌的标志中的作用:最新情况

Mercedes Bermúdez¹, Marcela Guadalupe Martínez-Barajas², Lesly Jazmín Bueno-Urquiza²

¹Faculty of Dentistry, Autonomous University of Chihuahua, Chihuahua 31000, Mexico.

|August 29, 2024

概括

微RNA-204-5p (miR-204) 通过抑制关键癌症特征,在乳腺癌 (BC) 中起到瘤抑制作用. 需要进一步的研究来探索其在BC的治疗潜力和预后价值.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

微RNA-204-5p (miR-204) 是一种小型非编码RNA,参与乳腺癌 (BC) 的发展.
miR-204影响癌症的基本特征,包括血管新生,入侵,迁移和转移.

研究的目的:

审查目前关于miR-204在乳腺癌特征中的作用的知识.
突出miR-204作为潜在的治疗标和BC的预后标志物.

主要方法:

在乳腺癌中调查miR-204的研究的文献综述.
对miR-204的调节机制和基因的分析.

主要成果:

miR-204通过向HIF-1α,β-catenin和VEGFA等基因来抑制血管生成,侵袭和转移等关键BC过程.
miR-204调节信号通路 (PI3K/AKT),与lncRNAs (HOTAIR,DSCAM-AS1) 相互作用,并影响瘤微环境和代谢重编程.
miR-204显示出作为瘤抑制剂的潜力,影响免疫细胞透和细胞因子产生.

结论:

miR-204在乳腺癌的进展中发挥着多方面的作用,作为关键瘤过程的抑制剂.
miR-204在BC中的复杂功能突出显示了其作为治疗标和预后生物标记物的潜力.
需要进一步的研究,以充分理解和利用miR-204在侵袭性BC.中的作用.

关键词:

乳腺癌乳腺癌乳腺癌癌症的特征癌症的特征在 miR-204 的情况下,微RNAs 是一个微型RNA.

更多相关视频

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...